Cargando…
Attacking the Intruder at the Gate: Prospects of Mucosal Anti SARS-CoV-2 Vaccines
The sudden outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic in December 2019 caused crises and health emergencies worldwide. The rapid spread of the virus created an urgent need for the development of an effective vaccine and mass immunization to achieve herd imm...
Autores principales: | Karczmarzyk, Kacper, Kęsik-Brodacka, Małgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876505/ https://www.ncbi.nlm.nih.gov/pubmed/35215061 http://dx.doi.org/10.3390/pathogens11020117 |
Ejemplares similares
-
Progress in biopharmaceutical development
por: Kesik‐Brodacka, Malgorzata
Publicado: (2017) -
Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study
por: Nawrot-Hadzik, Izabela, et al.
Publicado: (2021) -
Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
por: Mudgal, Rajat, et al.
Publicado: (2020) -
The SARS-CoV-2 UTR's Intrudes Host RBP's and Modulates Cellular Splicing
por: Singh, Anjali, et al.
Publicado: (2023) -
Intruder alarms
por: Honey, G
Publicado: (2003)